Thursday 27 September 2018

Trainee Video Session

Chairs: Roel Hompes (The Netherlands), Harald Rosen (Austria)

• How to handle misfired stapled colorectal anastomosis - Antonino Spinelli (Italy)
• The perfect stoma - how to avoid parastomal hernia - Muhammad Imran Aslam (UK)
• The ideal lap appendectomy: sometimes, not always! - Pierpaolo Sileri (Italy)
• Dissection for ileocolic Crohn's - Willem Bemelman (The Netherlands)
• Laparoscopic CME. What can go wrong? - Danilo Miskovic (UK)
• Anal fistula: New plugs, biologics - Carlo Ratto (Italy)
• Anal fistula: Flap - David Zimmerman (The Netherlands)
• Anal fistula: LIFT - Lilli Lundby (Denmark) 

New Trials Forum

Chair: Dion Morton (UK)

Expert panel: Aneel Bhangu (UK),Charles Knowles (UK), Christianne Buskens (The Netherlands), Jeremie Lefevre (France)

New Trials presentations: four proposals reviewed by the expert panel

• T01: DAMASCUS - Dale Vimalachandran (UK)
• T02: Electroacupuncture Combined with Fast-track Perioperative Program for Reducing Duration of Postoperative Ileus and Hospital Stay after Laparoscopic Colorectal Surgery: A Randomized Controlled Trial - Simon NG (China)
• T03: SELDDEC Trial - Ishwarya Balasubramanian (Ireland)
• T04: The NORWAIT Trial - Hartwig Kørner (Norway)

09:05 - 10:05
Small Hall 1

Free Papers: Neoplasia

Chairs: Beatriz Martin-Perez (Spain), Marcel Sadeghi (Sweden)

• F13: Influence of conversion and anastomotic leakage on survival in rectal cancer surgery; a large retrospective cross-sectional study - Edgar Furnée (The Netherlands)
• F14: Dose-effect relationship of metformin and its impact on long-term survival in colorectal cancer - Jia Lin Ng (Singapore)
• F15: A feasibility study of reporting patient reported outcome measures as part of a national colorectal cancer audit - Abigail Vallance (United Kingdom)
• F16: Sigmoid cancer: a hidden epidemic of local recurrence and R1 resections - Nigel D'Souza (United Kingdom)
• F17: Gender-specific cut-offs in colorectal cancer screening with FIT: increased compliance and equal positivity rate - Deborah Saraste (Sweden)
• F18: Postoperative abdominal infections after resection of T4 colon cancer increase the risk of intra-abdominal recurrence - Charlotte Klavers (The Netherlands)
• F19: Neoadjuvant (chemo)radiotherapy with TME only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multi-center lateral node study with 1216 patients with low cT3/4 rectal cancer - Miranda Kusters (The Netherlands)
• F20: Significant improvement in the local recurrence rate after partial mesorectal excision by critical evaluation of the extent and completeness of mesorectal excision with postoperative MRI - Peter Bondeven (Denmark)
• F21: Tumor sidedness is not an independent prognostic marker of colorectal cancer - Jothi Murugesan (Australia)

09:05 -10:05
Gailieni 1/2

Free Papers: Miscellaneous and Neoplasia

Chairs:  Torbjörn Holm (Sweden), Johannes Schultz (Norway)

• F22: Incidence of hernia after closure of a temporary loop ileostomy - Karolina Eklöv (Sweden)
• F23: Pre-operative oral antibiotic bowel preparation in elective resectional colorectal surgery reduces rates of surgical site infections - Bhamini Vadhwana (United Kingdom)
• F24: Hematic biomarkers for the early detection of anastomotic leak after colorectal resection. Results of the eden national prospective study - Matteo Frasson (Spain)
• F25: Critical care usage after major gastrointestinal and liver surgery: a prospective, multicentre cohort study - STARSurg Collaborative (United Kingdom)
• F26: Reporting variation in postoperative gastrointestinal recovery: cross-sectional review - Stephen Chapman (United Kingdom)
• F27: Patients with rectal cancer are satisfied with in-hospital communication despite insufficient information regarding treatment alternatives and potential side-effects - Sofie Walming (Sweden)

Keynote Lecture: Management of para-aortic and lateral pelvic lymph nodes in colorectal cancer

Chair: Ronan O'Connell (Ireland)

Speaker: Petr Tsarkov (Russia)

ESCP President's Address

Ethem Gecim (Turkey) - ESCP President

International Travelling Fellow Free Papers

Chairs: Ethem Gecim (Turkey), Emmanuel Tiret (France)

• ASCRS Visiting Fellow: Consolidation mFOLFOX6 Chemotherapy after Chemoradiotherapy Improves Survival in Patients with Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial - Michael Marco
• JSCP Visiting Fellow: Evaluation of the lymphatic flow at the splenic flexure in the laparoscopic colon cancer surgery - Jun Watanabe
• KSCP Visiting Fellow: Reduced-port robotic-versus multi-port laparoscopic surgery for left-sided colon cancer: clinicopathologic outcomes and patient scar assessment - Sung Uk Bae

The Six Best Free Papers

Chairs: Ethem Gecim (Turkey), Anna Martling (Sweden)

B1: Functional outcome in a randomised trial of early closure of Functional outcome in a randomised trial of early closure oftemporary ileostomy after rectal resection for cancer (EASY trial) - Jennifer Park (Sweden)

B2: Therapy refractory ulcerative colitis patients may benefit from appendicectomy; long-term clinical results from a multicenter prospective cohort series - Merel E. Stellingwerf (The Netherlands)

B3: The impact of social media on citation rates in coloproctology - Myung Jo Kim (Korea)

B4: Acute resection versus bridge-to-surgery with stent or decompressing colostomy in malignant left-sided colonic obstruction: a Dutch population-based analysis of 2587 patients - Joyce Veld (The Netherlands)

B5: Local excision after neoadjuvant radiochemotherpy for T2T3 rectal cancer: 5-year results of the GRECCAR 2 trial - Eric Rullier (France)

B6: The haemorrhoidal disease symptom score and short health scaleHD: new tools to evaluate symptoms and health-related quality of life in haemorrhoidal disease - Haavard Roervik (Denmark)

EuroSurg Student Session

Chairs: Francesco Pata (Italy), Aditya Borakati (UK), Tim van Elst (The Netherlands)

• Welcome and Introduction - Dion Morton (UK)
• IMAGINE Study: Preliminary Results - Steve Chapman (UK)
• EuroSurg group: future perspective - Ruth Blanco (Spain)
• PT Surg : developing a national network - Antonio Soares (Portugal)
• A practical approach to start a collaborative network - Dmitri Nepogodiev (UK)
• Small group discussion: how to develop a Surgical Research Collaborative

Research collaborative around the World 

Chairs: Gianluca Pellino (Italy), Aneel Bhangu (UK), Alessandro Sgrò (Italy)

• INCISION: a student group for Global Surgery - José Chen (Portugal)
• GlobalSurg collaborative - James Glasbey (UK)
• ASIT: Supporting Students and trainees collaborative in the UK and abroad - Christina Fleming (Ireland)
• EuroSurg 2019-2020: new project

ESCP/ECCO Symposium: Ulcerative Colitis

Chairs: Christianne Buskens (The Netherlands), Antonino Spinelli (Italy)

• Can surgeons influence Crohn's disease recurrence? - Andre D'Hoore (Belgium)
• Centralisation of IBD care: why and how? - Omar Faiz (UK), Ailsa Hart (UK)
• Impact of antibody therapy on surgical outcomes in IBD - Krisztina Gecse (Hungary), Jeremie Lefevre (France)

An ESCP session developed in collaboration with ECCO

ESCP/EAES Symposium: Screening and Surveillance

Chairs: Dieter Hahnloser (Switzerland), Giovanni Romano (Italy)

• Improvements in low anastomotic techniques - Francesco Bianco (Italy)
• Can we avoid an ileostomy? - Sebastiano Biondo (Spain)
• Early salvage of anastomotic failure - Pieter Tanis (The Netherlands)

A jointly organised EAES/ESCP session

ESCP Annual General Meeting

Keynote Lecture: Breath biopsy for colorectal cancer screening

Chair: Mark Katory (UK)

Speaker: Donato Altomare (Italy)

Free Papers: Neoplasia

Chairs: Katrine Emmertsen (Denmark), Michael Solomon (Australia), 

• F28: Watch-and-wait policy after radiotherapy in stage IV rectal cancer - Britt Hupkens (The Netherlands)
• F29: Hospital costs and oncological outcomes in locally advanced rectal cancer: standard treatment and watch-and-wait policy - Britt Hupkens (The Netherlands)
• F30: Early salvage TME following TEM in patients with rectal cancer: short and long-term outcomes in comparison with primary TME - Katarina Levic Souzani (Denmark)
• F31: Management of local regrowths in a watch-and-wait programme for rectal cancer - Marit van der Sande (The Netherlands)
• F32: Expanding the boundaries of resectability in pelvic exenteration. The price of higher and wider resections - Michael Solomon (Australia)
• F33: Effects of treatment with anti-coagulants on the immunochemical faecal occult blood test in the Danish screening programme for colorectal cancer - Simon Ladefoged Rasmussen (Denmark)

Free Papers: Neoplasia

Chairs: Monika Carpelan-Holmström (Finland), Aleksi Petrov (Russia)

• F34: A nationwide study on the adoption and surgical outcome since introduction of TaTME in the United Kingdom - Sapho Roodbeen (The Netherlands)
• F35: Organ-preservation among clinically Node-positive Rectal Cancer patients: is it really more dangerous? - Guilherme Pagin São Julião (Brazil)
• F36: KRAS mutation is associated with resistance to neoadjuvant chemoradiotherapy and reduced disease-free survival in patients with non hyper-mutated locally advanced rectal cancer - Michael Marco (USA)
• F37: Surgical management for obstructive left colon cancer at a national levelResults of a multicentre study of the French Surgical Association in 1220 patients - Diane Mege (France)
• F38: Patterns of metastasis and survival differences in patients with stage IV right-sided colon, left-sided colon and rectal cancer: results of the Netherlands Cancer Registry - Nelleke Brouwer (The Netherlands)
• F39: Faecal immunochemical test (FIT) can tell us if it's bowel cancer! - Aftab Khan (United Kingdom)